Recently, the US FDA approved initial combination therapy with sitagliptin and metformin (Janumet™) in order to help more patients with Type 2 diabetes mellitus get closer to accepted glycemic ...
Researchers from the US have shown that combination therapy with sitagliptin and metformin results in a substantial and additive glycemic improvement in patients with type 2 diabetes. Sitagliptin ...
Sitagliptin (Januvia™) is a new oral agent ... 1 Intent-to-treat population using last observation on study prior to metformin rescue therapy. *Least square means adjusted for prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback